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ABSTRACT Pulmonary surfactant is a complex mixture of lipids and proteins that lines the air/liquid interface of the alveolar
hypophase and confers mechanical stability to the alveoli during the breathing process. The desire to formulate synthetic
mixtures for low-cost prophylactic and therapeutic applications has motivated the study of the speciﬁc roles and interactions of
the different components. All-atom molecular dynamics simulations were carried out on a model system composed of
a monolayer of palmitic acid (PA) and a surfactant protein B peptide, SP-B1–25. A detailed structural characterization as
a function of the lipid monolayer speciﬁc area revealed that the peptide remains inserted in the monolayer up to values of
speciﬁc area corresponding to an untilted condensed phase of the the pure palmitic acid monolayer. The system remains stable
by altering the conformational order of both the anionic lipid monolayer and the peptide secondary structure. Two elements
appear to be key for the constitution of this phase: an electrostatic interaction between the cationic peptide residues with the
anionic headgroups, and an exclusion of the aromatic residues on the hydrophobic end of the peptide from the hydrophilic and
aqueous regions.
INTRODUCTION
Normal pulmonary function requires the presence of a
surface-active material at the air/liquid interface of the
alveolar hypophase. The endogenous pulmonary surfactant
is a complex mixture of ;90 wt % phospholipids and 10 wt
% apoproteins, which is produced, secreted, and recycled by
type II pneumocytes (Notter, 2000). The main physiological
action of pulmonary surfactant is the control of the surface
tension during breathing, allowing the stability and proper
mechanics of the alveoli.
Deﬁciency and dysfunction of pulmonary surfactant have
been associated with several respiratory diseases (Frerking
et al., 2001; Notter, 2000). The one with major incidence
(Notter, 2000) is neonatal respiratory distress syndrome
(NRDS) which affects premature infants. The conventional
clinical therapy for neonatal respiratory distress syndrome is
the replacement of the missing endogenous material, by
delivering to the alveoli an exogenous surfactant mixture
(Robertson and Halliday, 1998). The same concept has
started to be applied as a therapy for other forms of lung
disease (Frerking et al., 2001; Robertson and Halliday,
1998).
Both endogenous and exogenous pulmonary surfactant
accomplish their function through synergistic effects be-
tween the physicochemical properties of their components.
Although their main physiological action is the same, en-
dogenous pulmonary surfactant has a complex and delicate
life cycle that could account for the high diversity of
components. On the other hand, a material useful for the
replacement therapy is only required to perform the surface
activity function, namely, reduction of the work of breath-
ing, prevention of alveoli collapse, and promotion of lung
expansion.
The notion of synergy between components arises from
the competitive requirements of the physiological function.
Essential to the surfactant function is the reduction of surface
tension to values close to zero. This requires a close-packed,
fairly ordered ﬁlm, and accounts for the presence of di-
palmitoyl phosphatidylcholine (DPPC) as a major compo-
nent, ;40 wt % in mammals (Veldhuizen et al., 1998). At
the same time, to produce a uniform force throughout the
lung during the entire breathing cycle, the mixture must be
ﬂuid enough to maintain its integrity over a large range of
surface tension/alveolus area and have easy adsorption and
respreading. This function is accomplished by the presence
of unsaturated and anionic phospholipids and two of the four
surfactant proteins (SP), SP-B and SP-C (Notter, 2000;
Possmayer et al., 2001; Veldhuizen et al., 1998). SP-B and
SP-C are small hydrophobic proteins of 78 residues and 35
residues, respectively (Haagsman and Diemel, 2001).
Although it is still unclear whether or not SP-C has a speciﬁc
function related to the ﬁlm surface activity (Haagsman and
Diemel, 2001; Possmayer et al., 2001), it has been shown by
genetic ablation of the SP-B gene in mice (Clark et al., 1995),
that SP-B is indispensable to the breathing function.
The comprehensive study by Tanaka et al. (Tanaka et al.,
1986) showed that a mixture of DPPC, SP-B/C extracted
from bovine lung surfactant, anionic phospholipids from
natural extracts, and saturated fatty acids has the desired
surface activity as described above. The most recent evi-
dence from in vitro experiments supports the idea of
synergistic effects in multicomponent lipid and lipid/protein
mixtures. Captive bubble and Langmuir trough experiments
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(Discher et al., 1999; Piknova et al., 2001) have shown that
ﬁlms of a puriﬁed lipid mixture from extracts of calf
pulmonary surfactant exist, over a large range of surface
pressure up to ;70 mN/m, as a biphasic mixture in which
domains of a DPPC-rich liquid crystalline phase (liquid
condensed or tilted phase) are surrounded by an isotropic
liquid (liquid expanded) phase poor in DPPC. The action of
SP-B and SP-C has been studied in Langmuir trough
experiments on DPPC/DPPG (dipalmitoyl phosphatidylgly-
cerol) (Kru¨ger et al., 1999), DPPG/POPG (palmitoyl oleoyl
phosphatidylglycerol) (Takamoto et al., 2001), and DPPC/
POPG (Ding et al., 2001) systems, whereby it was de-
monstrated that the interaction between the anionic lipids
and SP-B and/or SP-C promotes the integrity of a biphasic
ﬁlm over a large range of surface pressure/area and tem-
peratures (Takamoto et al., 2001). In relation to the integrity
of the ﬁlm, a common outcome from these studies (Piknova
et al., 2001; Zasadzinski et al., 2001) is that the retention of
all the ﬁlm components in the air/liquid interface region is
related to a 2D to 3D transformation, apparently reversible,
within the liquid isotropic phase.
Although the importance of the interaction between SP-B
and anionic lipids to the proper performance of the
physiological function seems to be clear, the mechanisms
involved are not well understood (Possmayer et al., 2001;
Zasadzinski et al., 2001). This is an aspect of primary
importance to the development of new, more effective, and
less expensive formulations for replacement therapy. The
most successful replacement therapies are based on for-
mulations that include animal pulmonary surfactant or
pulmonary tissue extracts that contain the essential apopro-
teins SP-B and SP-C and are complemented with synthetic
lipids (Notter, 2000). However, the risk of disease trans-
mission, the desire for routine prophylactic applications, the
need for an uniform composition, and the limited availability
of the current formulations have prompted the development
of synthetic alternatives that could address these demands
while performing a similar function (Frerking et al., 2001;
Johansson et al., 2001).
One approach to the design of new exogenous surfactant
formulations is the combination of synthetic lipids with
synthetic peptides based on amphipathic regions of the
native sequence of human SP-B, or new sequences based on
the principles for the surface activity function of SP-B (Bruni
et al., 1991; Cochrane, 1998; Johansson et al., 2001; Longo
et al., 1993). One of these synthetic peptides that has re-
ceived considerable attention, and is the subject of the pre-
sent study, is the SP-B N-terminal peptide SP-B1–25 (Bruni
et al., 1991; Longo et al., 1993). SP-B1–25, an amphipathic
peptide with sequence FPIPLPYCWLCRALIKRIQAMIP-
KG, has been shown to exhibit surface activity resembling
that of the full SP-B protein (Lee et al., 1997; Takamoto et al.,
2001). The intermittency of cationic residues and the pre-
sence of a hydrophobic region, in this and other SP-B related
peptides, have been considered as structural motifs essential
to the surface activity. Results of monolayer (Longo et al.,
1993) and bilayer (Bruni et al., 1991) experiments with SP-
B1–25 mutants suggested that the lipid/peptide interaction has
both an electrostatic and hydrophobic character.
The surface activity and phase behavior of lipid mono-
layers with SP-B1–25 has been studied extensively (Bruni
et al., 1991; Ding et al., 2001; Flanders et al., 2000; Flanders
et al., 2002; Lee et al., 1997; Lee et al., 2001; Lipp et al.,
1998; Lipp et al., 1997; Longo et al., 1993; Takamoto et al.,
2001). In particular, a system that has received considerable
attention is palmitic acid (PA)/SP-B1–25. PA is an important
component in some of the formulations for replacement
therapy (Notter, 2000), however, the relevance of these
studies is primarily as a model system for the interaction of
SP-B with anionic lipids.
Fatty acid monolayers have long been considered as
suitable lipid monolayer model systems (Kaganer et al.,
1999), due mainly to the great variety of phases they present
as a consequence of a smaller headgroup than phospholipids.
By controlling temperature and subphase composition their
phase behavior is easily modiﬁed, and this has allowed a
complete characterization at the microscopic and atomic
scales (Kaganer et al., 1999).
In the case of PA, the gas-isotropic liquid-tilted condensed
phase triple point occurs at room temperature (Lipp et al.,
1998), and this has led to a comprehensive characterization
of the SP-B1–25 peptide/lipid interaction effects on the
monolayer constitution. Results from monolayer isotherms
and ﬂuorescence microscopy (Lee et al., 1997; Lipp et al.,
1997) established that the SP-B N-terminal peptide SP-B1–25
mimics the behavior and effects of the full protein on lipid
monolayers. Extensive characterization by diverse micros-
copy techniques (Flanders et al., 2000; Flanders et al., 2002;
Lee et al., 1997; Lipp et al., 1997), grazing incidence x-ray
diffraction (GIXD), and x-ray reﬂectivity (XRR) (Lee et al.,
2001) have shown that as a result of interaction between
SP-B1–25 and PA, a protein-rich ﬂuid or disordered phase
is formed in monophasic regions of the PA phase diagram
where the tilted condensed or liquid crystalline phase and the
untilted condensed (solidlike) phase are stable. The resulting
ﬁlms are biphasic with the disordered protein-rich phase
surrounding the ordered PA condensed phase. This change
from a single condensed phase in PA to a biphasic mixture in
PA/SP-B and PA/SP-B1–25 has a dramatic effect on the
stability of the monolayer, increasing its collapse surface
pressure from 40 mN/m in pure PA to about and above 60
mN/m in the PA/SP-B1–25 and PA/SP-B systems, respec-
tively (Lee et al., 1997; Lipp et al., 1997). The results of
XRR revealed that SP-B1–25 is partially inserted in the
monolayer disordered phase, forming and angle with the
interface normal (Lee et al., 2001).
In this paper we report molecular dynamics simulations of
the SP-B1–25 at 20 wt % in monolayers of PA with three
different surface densities at the air-water interface. We have
chosen this system for an initial atomic scale investigation of
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SP-B in lipid environments because its relatively small size
and complexity make it tractable for all-atom modeling, and
because it has been the subject of a series of experimental
studies. We have validated the simulation initial model by
a favorable comparison of our structural characterization
with the results obtained from XRR measurements. We have
developed a detailed description of the peptide location,
orientation, conformation, and interactions, as well as the
inﬂuence of the peptide on the conformation and packing of
the lipid hydrocarbon chains, as a function of compression in
the monolayer. The results presented here provide previously
lacking microscopic detail that complements the large body
of experimental data available on SP-B structure and
function.
METHODS
The initial system conﬁguration was based on a previously proposed model
(Tobias, 1998) for the location of the peptide in the PA/SP-B1–25 system. In
this model (Fig. 1), the peptide in a a-helical conformation was inserted in
the PA monolayer at an angle with respect to the normal to the air-water
interface. The location is such that the side chains of the cationic residues
Arg-12, Lys-16, and Arg-17 were located at the same level as the carboxyl
headgroups, whereas residues 1–8 were accommodated in the region of the
aliphatic chains.
This model was constructed based on the experimental data pertaining to
the conformation of SP-B1–25 in membrane mimic environments that was
available at the time that it was formulated (Gordon et al., 1996). In
particular, the model reﬂects results of polarized FTIR spectroscopy that
indicated an a-helix conformation in residues 8–25 with an orientation of
;458 to the lipid-water interface normal, electron spin resonance (ESR) data
showing that a N-terminal spin probe was located near the interface and that
the peptide was not aggregated in the lipid environment, and tryptophan
ﬂuorescence that suggested Trp-9 was associated with the lipid headgroups,
and absent from the aqueous phase.
To directly compare with experimental results (Lee et al., 1997; Lee et al.,
2001; Lipp et al., 1997), we have chosen to perform our study of the PA/SP-
B1–25 system at 168C. At this temperature PA monolayers are below their
gas-liquid-tilted condensed phase triple point (Lee et al., 1997; Lipp et al.,
1997). The monolayer condensation occurs through a gas to tilted condensed
phase transformation and, after further compression, the system presents
a second-order transition to an untilted condensed (solidlike) phase. As
indicated in the previous section, the presence of the peptide affects the
system phase behavior by inducing a disordered phase that persists up to the
monolayer collapse. The results from GIXD and XRR (Lee et al., 2001)
indicated that presence of the peptide does not affect the molecular packing
of the untilted condensed phase. Moreover, although the isotherms exhibit
a nonzero apparent compressibility in the region of the untilted condensed
phase, due to the biphasic nature of the monolayer, the second-order tran-
sition point is still evident at high peptide concentrations.
We carried out simulations at three different values of area per lipid,
corresponding to the following points of the 168C isotherm for the PA 20-wt
% SP-B1–25 system at pH 6.9 (0.15 M NaCl) (Lee et al., 1997; Lipp et al.,
1997): the middle point (34 A˚2/lipid), the ﬁnal point (26 A˚2/lipid) of the
tilted condensed phase region, and the ﬁrst point (24 A˚2/lipid) of the untilted
condensed phase region.
In all the simulations PA was taken to be fully ionized. The ionization
state of a fatty acid monolayer depends on the pH and ionic strength of the
aqueous subphase and the monolayer speciﬁc area. The ionization extent of
a fatty acid as a function of these variables is unknown, however, estimates
based on Gouy-Chapman theory are available (Lipp et al., 1997): for a pure
water subphase the extent of ionization is negligible, with estimates in the
range of 0.004–0.2%, and for a saline buffered subphase (pH 6.9, 150 mM
NaCl) the values range from 24% at 17 A˚2/molecule (168C) to 39% at 40 A˚2/
molecule (288C). Ideally, one should model a mixture of protonated and
deprotonated fatty acids, and establish equilibrium of the lateral disposition
of the species. However this is not plausible on the timescale that is presently
feasible for all-atom lipid monolayer simulations. It is reasonable to assume
that a peptide that carries a charge of 14 would prefer to interact with
ionized lipids. Moreover, as indicated in the previous section, the elec-
trostatic nature of the PA/SP-B1–25 interaction can be ascertained from the
experimental evidence. We have therefore decided that, as a ﬁrst attempt, it
is reasonable to assume a completely ionized monolayer.
The basic simulation setup consisted of two monolayers of PA placed on
opposite faces of a water slab. This conﬁguration allows the study of two
identical but independent systems in one single simulation. Each system was
placed in the center of an orthorhombic cell (Table 1), with the longest
direction normal to the air-water interface. A thickness of the water slab of
;42 A˚ and a simulation cell height of 200 A˚ were selected in order to avoid
long-range interactions along the direction normal to the air-water interface.
This conﬁguration allows the use of three-dimensional periodic boundary
conditions for the simulation systems, as well as spherical boundary con-
ditions for the long-range interactions.
Initially, the PA molecules had an all-trans conformation and were
arranged in a lattice with a herringbone order. A cluster of chains was re-
moved from the center of a previously equilibrated monolayer of PA at 21
FIGURE 1 Side view of the system initial conﬁguration.
TABLE 1 Simulation systems parameters
Area per
lipid (A˚2)
Number of
PA molecules*
Number of
water molecules
Cell
dimensions (A˚)
24 96 1280 33.80 3 35.47 3 200
26 96 1280 35.14 3 36.88 3 200
34 98 1659 37.35 3 44.80 3 200
*Each system also contained two SP-B1–25 peptides each with a net charge
of 4e, 8 Cl counterions, and Na1 counterions to neutralize the PA
molecules.
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A˚2/lipid, with the speciﬁc number removed dictated by the desired peptide
concentration and area per lipid. Sodium counterions where added to com-
pensate the charges of the PA headgroups by replacing randomly selected
waters. Likewise, chlorine ions were employed to compensate for the
peptide charges.
The CHARMM22 force ﬁeld (MacKerell et al., 1998) was used for the
lipids and peptides, and the TIP3P (Jorgensen et al., 1983) model was used
for water. The smooth particle mesh Ewald method (Essman et al., 1995)
was used to calculate the electrostatic interactions, and the van der Waals
interactions and the real space part of the Ewald sum were cutoff at 10 A˚
using a spherical truncation scheme. The simulations were carried out at
constant volume and a constant temperature of 168C using Nose´-Hoover
chain thermostats (Martyna et al., 1992). A reversible, multiple time step
algorithm (Martyna et al., 1996) was used to integrate the equations of
motion with a time step of 6 fs, and the lengths of bonds involving hydro-
gen atoms were held ﬁxed using the SHAKE-RATTLE-ROLL algorithm
(Martyna et al., 1996). The lengths of the simulations were 2.70 ns for the
systems with speciﬁc areas 26 and 24 A˚2/lipid, and 2.28 ns for the 34 A˚2/
lipid system. For all systems the analysis was carried out on the last 540 ps of
the simulations.
RESULTS AND DISCUSSION
Peptide location and interactions
with the monolayer
Fig. 2 shows the symmetrized total electron density proﬁle
for the three systems considered in this study, and the cor-
responding least-squares ﬁt to a four-box model as proposed
by Lee et al., (Lee et al., 2001) for their XRR results on
a similar sample. Each proﬁle is parsed into ﬁve regions: 1),
water bulk 2), peptide-water 3), peptide-headgroup 4),
peptide-tail, and 5), the remaining tail region. Box models
for density proﬁles across interfaces are constructed by
delimiting each region by a pair of step functions with
opposite sign, which in turn, are convoluted with a Gaussian
to account for overall roughness (Schalke and Lo¨sche, 2000).
Interfacial thermal broadening arises from two contributions:
capillary waves and intrinsic thermal agitation. Molecular
dynamics simulation systems like the ones reported here are,
in general, not large enough to present capillary waves. Total
electron density proﬁles only reﬂect the effect of volume
exclusion, which is assumed to be of the same order as
intrinsic thermal agitation. In general the effect of capillary
waves accounts for ;85% of the total roughness. Therefore
in order to perform the least-squares ﬁt of the total electron
density proﬁle to the proposed four-box model, we have
taken as a ﬁxed global roughness parameter the value of 2.3
A˚ reported by Lee et al (Lee et al., 2001). The corresponding
ﬁtted parameters are listed in Table 2.
Comparing with the four-box model parameters reported
by Lee et al. (Lee et al., 2001), the results from the
simulations are within the same range, suggesting that the
model presented here is a good candidate for the structural
characterization of the PA/SP-B1–25 ﬂuid mixture. A detailed
match or quantitative comparison with the experimental
results is precluded by the arbitrary choice of the global
roughness, the possibility that the scattered intensity of
speciﬁc peptide residues in the experiment is smeared out by
intrinsic thermal ﬂuctuations differing from the correspond-
ing volume exclusion, and differences in ionization and
hydration effects, given that the scattering experiments were
conducted on pure water.
For the systems of higher density, 24 A˚ 2/lipid and 26 A˚ 2/
lipid, the total thickness of the tail region is, respectively,
18.5 A˚ and 17.5 A˚. Comparing these values with the one for
an all-trans, upright pentadecanoic hydrocarbon chain of
18.765 A˚, tilt angles of 9.68 and 22.08 are obtained. These
values are in agreement with the results of direct calculations
presented in Table 3, indicating that the chains are not
FIGURE 2 Total absolute electron density proﬁles for 24 A˚2/lipid (solid
triangles), 26 A˚2/lipid (open squares), and 34 A˚2/lipid (solid squares). The
solid lines represent the corresponding least-square ﬁts to a four-box model.
The origin of the spatial coordinates is located in the center of the water slab.
TABLE 2 Fitted parameters to a four-box model for the interface structure
Tail Tail-peptide Head-peptide Peptide-water
Speciﬁc area
(A˚2/lipid)
Thickness
(A˚)
Relative
density
Thickness
(A˚)
Relative
density
Thickness
(A˚)
Relative
density
Thickness
(A˚)
Relative
density
34 9.0 0.71 6.6 0.96 2.6 1.38 9.1 1.02
26 11.2 0.92 6.2 0.97 2.6 1.44 9.4 1.04
24 12.4 0.96 6.1 1.02 2.5 1.41 9.3 1.04
25.3* 11.9 0.87 5.1 1.00 2.7 1.18 9.5 1.06
*Lee et al., 2001.
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perturbed globally by the presence of the peptide. It is
reasonable to conclude that the 24 A˚2/lipid and 26 A˚2/lipid
systems are at opposites sides of the second-order phase
transition, in agreement with the isotherm reported by Lipp
et al. (Lipp et al., 1997). The thickness values of the tail-
peptide and head-peptide regions in the three simulated
systems differ by less than 0.5 A˚ or half of the bin width.
This suggests that the same portions of the peptide are
accommodated in the monolayer hydrophobic and hydro-
philic regions through the whole range of stability of the
tilted condensed phase and up to the transition to the untilted
condensed phase.
Further consideration of electron density proﬁles for
a selected group of constituents provides additional insight,
not available from experiments, into the nature of the SP-B1–
25 interaction with the lipid monolayer. Fig. 3 shows the
symmetrized electron density proﬁles for water, aliphatic
chains, carboxyl headgroups, the aromatic side groups of
Phe-1, Tyr-7, and Trp-9, and the charged atoms of the four
cationic residues: Arg-12, Lys-16, Arg-17, and Lys-24. The
main feature present in these plots is that the distribution for
the four charged atoms is contained, almost in its entirety,
within the headgroup distribution. It is also noteworthy that
the distribution for the aromatic side groups is centered
around the maximum of the acyl chains distribution. The
distribution for the peptide charged atoms presents a second-
ary maximum in all three systems, for 34 A˚2/lipid cor-
responding to the Nz of Lys-24, which appears to be in the
water region; for 24 and 26 A˚2/lipid the Cz of Arg-12 extends
to the hydrophobic region. For all three systems the main
peak of the distribution corresponds to the charged atoms
TABLE 3 Average tilt angles with respect to the
interface normal
Speciﬁc area
Peptide tilt (8)
PA hydrocarbon
chain tilt (8)
(A˚2/lipid) Lower* Upper Lower Upper
34 43 6 1 42 6 2 24.5 6 11.8 31 6 14
26 55 6 2 52 6 2 21.9 6 5.9 18.1 6 9.0
24 48 6 1 46 6 1 9.1 6 6.0 10.7 6 8.5
*Lower and upper designations according to Fig. 1.
FIGURE 3 Absolute electron density proﬁles
and molecular graphics representation of se-
lected system components for (a) 24 A˚2/lipid,
(b) 26 A˚2/lipid, and (c) 34 A˚2/lipid. For clarity
the water molecules have been removed from
the graphical representations. Coloring scheme:
hydrocarbon chains, gray; carboxyl head-
groups, red; aromatic side chains, light blue;
positively charged side chains (snapshots), Arg
Cz and Lys Nz (density proﬁles), light green;
peptide backbone and other side chains, dark
green.
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of Lys-16 and Arg-17, which moves toward the center of
the headgroup distribution as the system density increases.
Changes in shape and displacement of the peptide distribu-
tions with speciﬁc area indicate that the peptide undergoes
signiﬁcant changes in its conformation, which are discussed
in more detail below. In contrast, there are no signiﬁcant
changes in the location or shape of the lipid distributions
that cannot be attributed to the normal ordering of the mono-
layer at the different speciﬁc areas. Both the water and the
aliphatic chains distribution present asymmetric shapes pro-
duced by exclusion effects due to presence of the peptide. In
the case of the density proﬁle for the aliphatic chains,
a nonuniform distribution is consistent with a local disrup-
tion of the orientational order as will be shown in detail in the
next section.
Further conﬁrmation of a predominant electrostatic in-
teraction between the peptide and the lipid monolayer was
obtained by computation of pair distribution functions
centered on Lys-16 Nz and Arg-17 Cz with headgroup oxy-
gens and water oxygens. Representative results are shown in
Fig. 4 for the 24-A˚2/lipid system. The distribution functions
for pairs formed with headgroup oxygens present a sharp
ﬁrst peak at 2.875 6 0.25 A˚ for Lys-16 and 3.375 6 0.25 A˚
for Arg-17. For all the systems under study, it was found that
on average there are at least two different lipid headgroups in
the ﬁrst coordination shell of the charged molecular groups
of Lys-16 and Arg-17. Detailed results are presented in Table
4. The average number of headgroups in contact with
a charged residue increases with the density of the lipid
monolayer, and the number of waters decreases. Although
water oxygens were found in some cases in the ﬁrst coor-
dination shell, no correlation was found between residues
and the amount of water present. Therefore, it does not seem
relevant to specify a speciﬁc hydration level for these
residues. Also, spatial correlations between the cationic
residues and chlorine counterions were not found. These
results suggest that electrostatic interactions between the
peptide and solution counterions are unlikely.
The body of results presented so far suggest that the
anchoring of the peptide by electrostatic interactions be-
tween its charged residues and the lipid headgroups, and the
total exclusion of the aromatic residues from the hydrophilic
region, are the key elements that allow the peptide to remain
associated with the lipid monolayer throughout the whole
range of stability of the condensed phases and, therefore,
appear to be crucial to the stability of the ﬂuid mixture PA/
SP-B1–25. These interactions are evident in the system
snapshots shown in Fig. 3.
The model presented above is consistent with the behavior
reported for SP-B and SP-B1–25 in the presence of anionic
lipids. The speciﬁc interaction between bovine SP-B and
DPPG headgroups in DPPC/DPPG bilayers was shown to
induce ordering without considerably perturbing the interior
of the membrane (Baatz et al., 1990). Kru¨ger et al. (Kru¨ger
et al., 1999), employing SP-B/C in concentrations that
closely resemble the endogenous lung surfactant and con-
trolling the subphase pH, concluded that the interaction of
the proteins with DPPC/DPPG monolayers had an electro-
static character. As was indicated in the previous section, all
the experimental evidence points to a partial insertion of
SP-B1–25 in PA and other lipid monolayers with anionic
components through an electrostatic interaction.
Monolayer orientational order
As mentioned above, the presence of nonuniform distribu-
tions for the electron density of aliphatic chains (cf. Fig. 3)
can be taken as an indication of local breaking of the lipid
monolayer order. To gain insight into the different effects that
the presence of the peptide could have on the monolayer
ordering, we have conducted a detailed analysis of the ali-
phatic chains orientational order in the higher density systems.
The analysis was performed separately for the two inde-
pendent monolayers in each system.
The ordering of lipid monolayers in the condensed phases
is strongly dependent on the aliphatic chain correlations. As
a measure of the degree of chain packing and correlation, we
have computed the skeletal order parameter (SCC) deﬁned as
SCC ¼ 1
2
h3 cos2 uj  1i;
where uj is the angle between the interface normal and the
vector deﬁned by the position of Cj1 and Cj11, and the
angular brackets denote an average over molecules and time.
The fully ordered all-trans untilted chains state corresponds
to a value of SCC ¼ 1, whereas a fully random orientation
would give SCC ¼ 0 (Ben-Shaul, 1995). We have com-
plemented this analysis by calculating the average fraction
of gauche conformations per bond.
Fig. 5 shows plots of SCC versus carbon number for
the 24-A˚2/lipid and 26-A˚2/lipid systems. The designation as
upper and lower monolayer corresponds to the orientation
shown in Fig. 1. Clearly, in these systems, there are two
distinct levels of orientational order: for those chains far
from the peptide a typical dependency of highly correlated
packing is observed, whereas for those chains next to the
peptide the orientational long range order appears to have
been broken.
As indicated before, at these values of speciﬁc area it is
expected that the lipid chains are in a fully ordered
conformation with a degree of packing given by the speciﬁc
orientation of the chain director. This behavior is manifested
in all four cases, for the chains far from the peptide, as
a predominantly constant SCC proﬁle. In each case the SCC
mean value, excluding the end carbons, is consistent with the
chain tilt angle reported in Table 3.
The set of chains considered as being next to the peptide
includes all of the peptide nearest neighbors and those
second neighbors whose conformation appeared to be af-
fected by the presence of the peptide (top view snapshots
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of each monolayer are presented in Fig. 7). They represent
25% and 23% of the total number of chains for 24 A˚2/lipid
and 26 A˚2/lipid, respectively. The form of the SCC proﬁle for
these groups is consistent with a liquidlike isotropic phase
(Ben-Shaul, 1995) where there is a monotonic decrease of
the order parameter toward the terminal methyl group.
The analysis of the 24-A˚2/lipid monolayers also reveals
that the presence of the peptide could affect chain packing in
different ways. A close comparison between SCC proﬁles for
the upper and lower monolayers (Fig. 5, a and b), shows that
for the lower monolayer the ordering in the two regions is
correlated at least up to C9, although for the upper monolayer
there is no apparent relationship between them. Comparing
the probability distributions of gauche conformations
(Fig. 6, a and b), the upper monolayer exhibits a more
uniform distribution of gauche conformations along the
chain than the lower monolayer. The latter shows an
alternate distribution precisely up to C9. This result indicates
that it would be more likely to ﬁnd kinks in the lower
monolayer than in the upper monolayer. Visual inspection of
the upper monolayer (Fig. 7) revealed the occurrence of
chain collapse in this system.
This contrasting behavior among monolayers with the
same speciﬁc area could be understood as two plausible but
different conformational effects induced by the presence of
the peptide. In the upper monolayer the peptide has induced
chain melting and chain collapse in its ﬁrst coordination
shell. The results for the lower monolayer are interpreted as
a result of the lack of constraint on the azimuthal orientation
of the chains; the peptide coexists with ordered domains with
the same director but different azimuthal orientation. The
presence of these domains was observed by visual inspection
(see Fig. 7) and then conﬁrmed by the chain azimuthal angle
distribution (results not shown). The lower monolayer
presented a bimodal distribution whose maxima are se-
parated by 608 as it can be expected in a close-packed ar-
rangement. On the other hand, for the upper monolayer
a single asymmetric broad peak accompanied by a secondary
low magnitude distribution spread over more than 1008 has
replaced the bimodal distribution. This result is consistent
with the picture of coexistence of a large ordered region with
a speciﬁc azimuthal orientation and a limited disordered
region.
The analysis of the monolayers with a speciﬁc area of 26
A˚2/lipid reveals a similar behavior to the upper monolayer
with 24 A˚2/lipid. Nevertheless, a few signiﬁcant difference
were found: the SCC proﬁles for the chains near the peptide
FIGURE 4 Pair distribution functions for 24 A˚2/lipid
centered on (a and c) Lys-16 Nz; (b and d ) Arg-17 Cz . The
solid line corresponds to pairs with headgroup oxygens,
broken line corresponds to pairs with water oxygens. a and
c correspond to the upper layer in Fig. 1; b and d correspond
to the lower layer.
TABLE 4 Average coordination number for the peptide
charged groups
Speciﬁc area (A˚2/lipid)
24 26 34
Pair Lower* Upper Lower Upper Lower Upper
Arg-12 – headgroup 3 2 2 1 0 2
Lys-16 – headgroup 2 2 3 2 2 2
Arg-17 – headgroup 3 2 3 2 1 2
Lys-24 – headgroup 3 3 1 3 1 2
Arg-12 – water 0 0 2 0 1 0
Lys-16 – water 0 1 0 0 1 1
Arg-17 – water 0 0 0 0 2 1
Lys-24 – water 0 0 1 0 0 1
*Lower and upper designations according to Fig. 1.
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appear to follow closely the same trend as the proﬁle for the
ordered region (Fig. 5), and these systems present a more
uniform distribution of gauche conﬁgurations along the
chain (Fig. 6). These differences with respect to the system
of higher density are readily attributable to the larger speciﬁc
area.
Fluorescence microscopy experiments (Kru¨ger et al.,
1999; Lee et al., 1997) have shown that in lipid monolayer
systems containing SP-B and SP-B1–25, the protein is located
in the regions rich in the ﬂuorescent-labeled lipid, suggesting
that the lipid/SP-B mixture conforms to a ﬂuid or disordered
phase. At high surface pressure this ﬂuidized phase forms
a network around domains of ordered condensed phases. For
the PA/SP-B1–25 system, contrasting their XRR and GIXD
FIGURE 5 Skeletal order parameter (Scc) versus
carbon number for (a and b) 24 A˚2/lipid and (c and
d ) 26 A˚2/lipid . The solid squares represent the region
near the peptide. The open symbols represent regions
away from the peptide. a and c correspond to the upper
layer in Fig. 1; b and d correspond to the lower layer.
FIGURE 6 Gauche fraction versus bond index for (a
and b) 24 A˚2/lipid and (c and d ) 26 A˚2/lipid. The solid
squares represent the region near the peptide. The open
symbols represent regions away from the peptide. a and
c correspond to the upper layer in Fig. 1; b and
d correspond to the lower layer.
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results, Lee et al. (Lee et al., 2001) concluded that the
mixture PA/SP-B1–25 is disordered. Moreover, they modeled
their PA/SP-B1–25 reﬂectivity spectra as a biphasic mixture
of ordered PA and disordered PA/SP-B1–25 with a distribu-
tion of submicron sized domains. These experimental
ﬁndings are consistent with the picture that arises from our
analysis of the monolayer orientational order. Our results
reveal that the action of the SP-B1–25 peptide on the order of
the lipid monolayer has a local character. In other words, by
taking advantage of a nonrestricted azimuthal orientation
degree of freedom, a statistical picture of an untilted con-
densed phase can be consistent with having local conforma-
tional defects. This would allow the lipid/peptide mixture
to coexist with ordered domains over a wide range of sur-
face pressure, area fractions, and microstructural arrange-
ments. The diverse forms in which disorder is introduced in
the lipid monolayer condensed phases, manifested by the
possibility of distributing gauche defects in either a localized
way around the peptide or as small domains over larger
areas, suggest that a mechanically stable boundary could
exist between the peptide-rich ﬂuid phase and the lipid
ordered phase, allowing the formation of the patterns or
textures that have been observed experimentally: a dispersion
of the ordered condensed phase in a ﬂuid phase matrix. This
kind of microstructure appears to be required to perform the
full breathing cycle continuously and reversibly.
Peptide orientation and conformation
As was shown before (cf. Figs. 2 and 3) the peptide remains
ﬁrmly lodged in the monolayer for all the speciﬁc areas
studied. However, its conformation changes as revealed by
the changes in the density proﬁles shown in Fig. 3. These
changes are consistent with the phase evolution of the lipid
monolayer from a low density tilted condensed state at 34
A˚2/lipid to a high density untilted condensed state at 24 A˚2/
lipid. Details of the peptide conformation as a function of the
system speciﬁc area are shown in Fig. 8 and Table 3. In
FIGURE 7 Top view of the lipids backbone for (a
and b) 24 A˚2/lipid and (c, and d) 26 A˚2/lipid. All the
views are along the backbone axis of the same group of
molecules. a and c correspond to the upper layer in
Fig. 1; b and d correspond to the lower layer. For
comparison purposes a top view of the lipids backbone
for an equilibrated PA monolayer without peptide, at 21
A˚2/lipid and 168C, is also shown: (e) view along the
interface normal; ( f ) view along the backbone axis.
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Fig. 8, the SP-B1–25 backbone dihedral angles (f, c) from
average structures ([540 ps) are plotted on Ramachandran
maps. The values are plotted separately for each peptide in
the independent monolayers in each simulation. The average
angle between the peptide long axis (the largest moment of
inertia) and the interface normal is listed for each system in
Table 3. Taken together these results indicate that for the
systems of higher density (24 and 26 A˚2/lipid), as the speciﬁc
area decreases, the corresponding decrease in the peptide tilt
angle with respect to the interface normal is accompanied by
a decrease in the fraction of right-handed a-helical con-
formation. The divergence of the system at 34 A˚2/lipid from
this last result is an indication of a lack of conformational
correlation between the lipid monolayer and the peptide.
For the two systems of higher density (24 and 26 A˚2/lipid)
the partitioning of the peptide helix fraction occurs in two
different forms, as indicated by the representative snapshots
showed in Fig. 9. In one case, the a-helix segment occurs
around Lys-16 and Arg-17, which the electron density
proﬁles and pair distribution functions revealed as the core
region for anchoring between the lipid monolayer and the
peptide. The second form consists of two separate fractions
FIGURE 8 Ramachandran plot for SP-B1–25
at (a and b) 24 A˚2/lipid; (c and d) 26 A˚2/lipid,
and (d and e) 34 A˚2/lipid. a, c, and e correspond
to the upper layer in Fig. 1; b, d, and f cor-
respond to the lower layer in Fig. 1. The back-
ground contours were obtained from the
program MOLMOL (Koradi et al., 1996) and
represent the allowed regions from 378 differ-
ent crystal structures with a resolution of at
least 2.5 A˚. The three shades of gray indicate,
from dark to light, 80%, 95%, and 98% of the
sample.
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extended along the monolayer hydrophobic and hydrophilic
regions with Lys-16 and Arg-17 in a random conformation.
These two conformations are correlated with the order in the
monolayer: the single helix fraction corresponds to the upper
monolayer with a more uniform distribution of gauche
defects along the chains near the peptide, whereas the double
partitioning corresponds to the lower monolayer whose
gauche defects distribution is concentrated on both chain
ends.
Overall our simulations suggest that the peptide loses
some of its helical conformation and becomes more elon-
gated as the monolayer is compressed. This allows the
peptide to remain in the ﬁlm despite the reduction in the
volume available for it to occupy. The mechanical stability
of the monolayer at high surface pressure is not impacted by
the presence of the peptide, as the change in secondary
structure acts as a spring-load mechanism, releasing strain
energy as it goes from a helix conformation at large speciﬁc
areas to a coil conformation at high compression.
The structural conformations of SP-B1–25 have been
characterized in samples in organic solvents or phospholipid
membrane mimetics (Gordon et al., 1996; Gordon et al.,
2000). The most detailed analysis is found in a recent study
that combines results of 13C-enhanced FTIR of SP-B1–25
in POPG liposomes with molecular modeling techniques
(Gordon et al., 2000). These authors reported an a-helix
conformation for residues 8–22 and b-sheet for residues 1–6.
However, none of the experimental systems indicated could
be considered as a model of pulmonary surfactant as they
lack the necessary characteristics of high-density lipid
packing and long-range orientational order. Moreover, it
is conceivable that the peptide location and orientation in
the lipid matrix could be different in lipid monolayers and
bilayers. Consequently, structural arrangements in these sys-
tems do not manifest the lipid/peptide synergistic effects
characteristic of the interaction in the pulmonary surfactant.
In the context of these studies some attempts were made to
qualitatively illustrate the location of SP-B1–25 in a lipid
monolayer (Gordon et al., 1996; Lee et al., 2001). No
comparison can be made between those representations and
the results presented here, as the former do not constitute the
outcome of a peptide modeling in an inhomogeneous lipid
monolayer environment.
SUMMARY
An atomistic model for the PA/SP-B1–25 monolayer has been
presented and shown to be stable in a wide range of lipid
speciﬁc areas in the region of the monolayer tilted and
untilted condensed phases. The structural characterization
suggests that two elements are key for the constitution of
this phase: an electrostatic interaction between the cationic
peptide residues and the anionic lipid headgroups, and an
exclusion of the aromatic residues on the hydrophobic end of
the peptide from the hydrophilic and aqueous regions. The
system remains stable at very high densities by a breaking
of the conformational order of both the peptide secondary
structure and the lipid aliphatic chains. The diverse forms in
which the disorder is manifested suggest that there are con-
formational pathways that would allow the system to form
a mechanically stable interface between the ﬂuid peptide-rich
phase and a highly ordered lipid condensed phase.
This work was supported in part by the National Science Foundation (grant
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